The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

A study involving 22 Parkinson's disease (PD) patients has shown that use of the dopaminergic drug levodopa improves sleep quality. When the patients took the drug, the number of times they woke ...

Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is limited by the development of psychiatric complications, including a disorder ...

Find all the commercial and brand names of generic drug called Levodopa. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

The global Parkinson’s disease (PD) market is expected to grow to $7.9 billion by 2033 from $3.4 billion in 2023, according ...

Expert Rev Neurother. 2009;9(7):929-940. Improvements in levodopa pharmacokinetics with the addition of entacapone were similar to that seen in healthy volunteers. In addition, Phase II trials ...

These dopamine deficiency symptoms can usually be controlled for many years, but eventually patients develop motor complications during chronic levodopa therapy, and nondopaminergic problems ...

Find all the commercial and brand names of generic drug called Carbidopa-Levodopa . This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need ...

MM PD market growth will be driven by advancements in innovative therapies, including the first DMTs, and a growing patient ...